Boots
This article was originally published in The Rose Sheet
Executive Summary
Novartis Consumer Health appointed Clearasil distributor in U.S. and Canada, effective July 2, to strengthen position of skin care brand, UK firm announces. Former Clearasil marketer Procter & Gamble will distribute brand until July 1 and will continue to manufacture it in North America until further notice, Boots says. Novartis and Boots will work together to evaluate opportunities for Clearasil, including product revamp and possibility of bringing other Boots products in development to U.S., firm says. Boots purchased Clearasil for $340 mil. last fall in effort to gain access to U.S. OTC market (1"The Rose Sheet" Oct. 23, 2000, p. 3)